News | June 30, 2011

Long Beach Hospital Advances Care of Coronary Artery Disease With New Optical Coherence Tomography Platform

June 30, 2011 — The MemorialCare Heart and Vascular Institute (MHVI) at Long Beach Memorial has acquired the C7-XR OCT intravascular imaging system from St. Jude Medical. It is an imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease. Using optical coherence tomography (OCT), the system utilizes near-infrared light to create images that go beyond older coronary imaging technologies -- such as fluoroscopy and intravascular ultrasound (IVUS) -- offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease.

The system allows physicians at Long Beach Memorial to visualize and measure important vessel characteristics otherwise invisible or difficult to assess with previous intracoronary imaging technology. It can assist physicians in stent selection by providing them with precise measurements of lesion dimensions and vessel size and structure.

“The C7-XR System can be especially important for the assessment of stent placement because the high-resolution images show precisely how the stent is holding the artery open and whether it is positioned correctly against the artery wall, optimizing treatment and follow-up strategies,” said Rex Winters, M.D., medical director of invasive technology, MHVI.

In addition to guiding stent selection, the system provides physicians with post-stenting information, potentially minimizing the risk of repeat revascularization, where the patient would need to have another surgery to restore blood flow to an organ or tissue. At follow-up, the OCT technology provides detailed information regarding the inner lining of the vessel and whether there is a reoccurrence of the blood vessel narrowing.

The OCT technology platform creates images with 10 times the resolution of IVUS. The superior resolution and depth of focus found in OCT images aids in optimizing stent selection, evaluating stent apposition and the precise assessment of lesion morphology.

The C7-XR system with the C7 Dragonfly imaging catheter was launched in Europe in May 2009 and the M3 OCT imaging system had been the only commercially available intracoronary OCT imaging device in the world. The C7-XR is commercially available in the United States.

For more information:

Related Content

Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Avinger, VISION Study, two-year outcomes, LINC, Lumivascular technology, Pantheris, OCT-guided atherectomy
News | Atherectomy Devices| February 03, 2017
Avinger Inc. recently announced positive two-year clinical data from the pivotal VISION study of the company’s...
Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging| January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S.
Videos | TCT| November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents| November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
OCT, optical coherence tomography, coronary stent implantation, superior resolution, TCT 2016, ILLUMIEN III OPTIMIZE PCI Trial
News | Optical Coherence Tomography (OCT)| October 31, 2016
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary...
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award
News | Optical Coherence Tomography (OCT)| September 27, 2016
Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans...
News | Peripheral Artery Disease (PAD)| August 22, 2016
Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,800 shares of Avinger’...
Overlay Init